Administrative Core
行政核心
基本信息
- 批准号:8411734
- 负责人:
- 金额:$ 18.83万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-01 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:Advisory CommitteesAnticonvulsantsAreaChemicalsCollaborationsCommittee MembersCommunicationCommunitiesDataDatabasesEducational workshopEnsureEnvironmental HealthFosteringFundingGoalsGrantHuman ResourcesIntoxicationLaboratoriesLeadershipLogisticsManuscriptsMedical ResearchMissionMonitorOnline SystemsPoliciesPreparationProtocols documentationPubMedReagentRegulationReportingResearchResearch InstituteResearch PersonnelResearch Project GrantsResource SharingSafetySecureSecuritySeriesStrategic PlanningSystemTherapeuticTraining and EducationUnited States National Institutes of HealthUniversitiesWorkdata managementdata sharinginterestmeetingsmembernoveloperationprogramsstatisticssynergismweb site
项目摘要
Summary: Administrative Core personnel, including the Director, Associate Director, and three staff (Administrative Program Manager, Technical Manager and Assistant Technical Manager), will oversee and coordinate the scientific and administrative operations of the Center's activities and foster interactions and synergism among Center research projects and scientific cores with the ultimate goal of ensuring that the Center meets the annual milestones established in collaboration with NIH CounterACT program officer(s).
Additionally, the Administrative Core will coordinate interactions with the NIH CounterACT administration, our External Advisory Board and the general CounterACT research community.
The specific aims of the
Administrative Core encompass five areas of administrative responsibility:
Aim 1: Develop a strategic plan for achieving annual Center and project milestones and ensure its effective and efficient implementation.
Aim 2: Provide scientific leadership and logistical support to coordinate and integrate Center activities and promote interactions among Center investigators.
Aim 3: Facilitate data and resource sharing among Center investigators and other CounterACT investigators.
Aim 4: Provide budgetary oversight and grants management.
Aim 5: Ensure the safety and security of personnel, materials, data and facilities.
简介:行政核心人员,包括主任、副主任和3名工作人员(行政项目经理、技术经理和助理技术经理);将监督和协调中心活动的科学和行政运作,促进中心研究项目和科学核心之间的互动和协同作用,最终目标是确保中心达到与NIH抵消项目官员合作建立的年度里程碑。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Pamela J Lein其他文献
Pamela J Lein的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Pamela J Lein', 18)}}的其他基金
Project 1: Reduction of Pro-Inflammatory Signaling
项目 1:减少促炎症信号传导
- 批准号:
10684082 - 财政年份:2022
- 资助金额:
$ 18.83万 - 项目类别:
Ketogenic diet approaches to slow disease progression in a rat model of Alzheimer's disease
生酮饮食方法可减缓阿尔茨海默病大鼠模型的疾病进展
- 批准号:
9977496 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Identifying Molecular Targets for the Proconvulsant Activity of TETS
确定 TETS 促惊厥活性的分子靶点
- 批准号:
9905564 - 财政年份:2019
- 资助金额:
$ 18.83万 - 项目类别:
Does air pollution increase risk of AD in a genetically susceptible animal model?
空气污染是否会增加遗传易感动物模型患 AD 的风险?
- 批准号:
9126737 - 财政年份:2016
- 资助金额:
$ 18.83万 - 项目类别:
Mitigation of Neurological Damage Following Seizures
减轻癫痫发作后的神经损伤
- 批准号:
10204125 - 财政年份:2012
- 资助金额:
$ 18.83万 - 项目类别:
Novel Anticonvulsant and Neuroprotective Therapies for TETS and OP Intoxication
针对 TETS 和 OP 中毒的新型抗惊厥和神经保护疗法
- 批准号:
10204117 - 财政年份:2012
- 资助金额:
$ 18.83万 - 项目类别:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
针对 TETS 和 OP 中毒的新型抗惊厥药和神经保护疗法
- 批准号:
9142832 - 财政年份:2012
- 资助金额:
$ 18.83万 - 项目类别:
Novel anticonvulsant and neuroprotective therapies for TETS and OP intoxication
针对 TETS 和 OP 中毒的新型抗惊厥药和神经保护疗法
- 批准号:
8925299 - 财政年份:2012
- 资助金额:
$ 18.83万 - 项目类别:
相似海外基金
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10004277 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10475298 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10693904 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10013749 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Study on how anticonvulsants affect car driving
抗惊厥药如何影响汽车驾驶的研究
- 批准号:
20K17977 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10266034 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents
用于神经毒剂的新型水溶性辅助抗惊厥药
- 批准号:
10475109 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Novel pediatric anticonvulsants for nerve agents
用于神经毒剂的新型儿科抗惊厥药
- 批准号:
10248384 - 财政年份:2020
- 资助金额:
$ 18.83万 - 项目类别:
Prevention of neuropathic pain by antidepressants and anticonvulsants: in vivo patch-clamp analysis
抗抑郁药和抗惊厥药预防神经性疼痛:体内膜片钳分析
- 批准号:
24592355 - 财政年份:2012
- 资助金额:
$ 18.83万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Anticonvulsants, ischemic seizures and regeneration in the immature brain
抗惊厥药、缺血性癫痫发作和未成熟大脑的再生
- 批准号:
8492175 - 财政年份:2009
- 资助金额:
$ 18.83万 - 项目类别:














{{item.name}}会员




